We are using cookies This website uses cookies in order to offer you the most relevant information. By browsing this website, you accept these cookies.
This risk is the result of traditional and nontraditional CVD risk factors.
2
Predicted and observed CVD-free survival showed good agreement in all validation sets.
3
Heightened risk of CVD is often attributable to treatment with anthracycline chemotherapy.
4
Participants: Participants with self-reported history of established diagnosis of CVD were excluded.
5
Age-associated changes of such cells may enhance the risk of developing CVD.
1
Background: Left ventricular mass offers prognostic information for assessing cardiovasculardisease risk.
2
Background: Education is inversely associated with cardiovasculardisease incidence in developed countries.
3
Context: The risk factors for cardiovasculardisease and erectile dysfunction are similar.
4
Objective: Microalbuminuria is associated with increased risk of cardiovasculardisease and mortality.
5
Background: Moderate alcohol consumers have lower rates of cardiovasculardisease than abstainers.
1
Leading causes of death were due to nutrition and metabolic diseases followed by diseasesofthecirculatorysystem.
2
Diseasesofthecirculatorysystem (mainly acute myocardial infarction) and fractures were the most common reasons for hospitalisation of European patients abroad.
1
Objective: Cigarette smoking is an important modifiable risk factor for cardiovasculardiseases.
2
The risk for developing cardiovasculardiseases was not different between the groups.
3
Background and purpose: PDGF-BB is an angiogenic factor involved in cardiovasculardiseases.
4
Conclusion: Telomere shortening has been reported in several metabolic and cardiovasculardiseases.
5
The Company is principally focused on developing genetically-targeted therapies for cardiovasculardiseases.
Usage of cv disease in English
1
Subclinical CVdisease was associated with age and dyslipidemia but not with other risk factors.
2
These effects seem particularly important for reducing risk of CVdisease in patients with the metabolic syndrome.
3
This study provides preliminary data for developing an integrated model of multidisciplinary care for the management of CVdisease.
4
Increasing the understanding of the pathogenesis of various CVdiseases may provide novel therapeutic targets to improve their prevention and treatment.
5
The metabolic syndrome (MS) represents a cluster of cardiovascular (CV ) risk factors associated to CVdisease and type 2 diabetes.
6
Additionally, recent studies suggest that GnRH antagonists may significantly reduce CV risk compared to GnRH agonists, particularly in men with pre-existing CVdisease.
7
Because AstraZeneca's study also looked at patients without established CVdisease, it potentially opens up a larger market that also covers so-called primary prevention.
8
Coronary and CVdisease biomarkers in UWS correlated better with serum than with LS and GS based on group status and measures of time effect.